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Table 1
Variable
HCM
(n¼36) HT (n¼10)
Normal
(n¼10)
p (HCM
vs HT)
p (HCM vs
Control)
p (HT vs
Control)
Age 46.314.6 60.48.7 42.211.2 0.008* 0.49 0.001*
Male/Female 21/15 7/3 8/2 0.93 0.21 0.33
Septal thickness
(mm)
24.76 16.32,4 11.31 0.005* < 0.0001* < 0.0001*
Posterior wall
thickness (mm)
13.12.6 14.51.6 10.60.52 < 0.0001* 0.002* < 0.0001*
Septum/posterior
ratio
1.940.53 1.120.09 1.070.08 0.076 < 0.0001* 0.28
LV mass (gr) 406.8111.7 303.261.5 181.429.8 < 0.0001* < 0.0001* < 0.0001*
LV end-diastolic
diameter (mm)
44.86.3 46.25.5 45.53 027 0.67 0.32
LV end-systolic
diameter (mm)
24.75 26.35.1 25.42.4 0.42 0.53 0.74
Mitral E velocity
(cm/s)
0.760.18 0.60.12 0.70.13 0.013* 0.35 0.14
Mitral A velocity
(cm/s)
0.610.21 0.70.11 0.640.14 0.07 0.49 0.11
Mitral E
Deceleration
Time (ms)
193.464.3 22554.4 22050.7 0.90 0.15 0.80
Mitral Septal
Sa (cm/s)
7.32.1 6.61.01 8.71.6 0.31 0.07 0.01*
Mitral Septal Ea
(cm/s)
5.061.6 5.51.7 9.43 0.49 < 0.0001* 0.003*
Mitral Septal Aa
(cm/s)
7.51.8 81.04 10.31.8 0.53 < 0.0001* 0.007*
Mitral Lateral Sa
(cm/s)
8.22 7.31.1 9.51.7 0.19 0.11 0.005*
Mitral Lateral Ea
(cm/s)
8.73.1 6.82.5 113.1 0.09 0.06 0.019*
Mitral Lateral Aa
(cm/s)
8.82.5 9.92.7 9.41.8 0.26 0.36 0.54
Mitral Septal E/Ea 16.26.1 11.93.3 8.12.8 0.09 < 0.0001* 0.019*
Mitral Lateral E/Ea 9.53.5 9.92.9 6.82.0 0.65 0.009* 0.014*
Global Longitudinal
Strain (%)
-10.82.7 -14.62.3 -16.32.0 < 0.0001* < 0.0001* 0.12
Global Radial
Strain (%)
11.94.5 18.56 18.54.8 0.001* 0.001* 0.35
Global
Circumferential
Strain (%)
-13.93.3 -15.12.5 -16.21.8 0.35 0.001* 0.45
Anterolateral
Papillary
Muscle Strain (%)
-16.75.6 -225 -21.73.6 0.009* 0.008* 0.91
Anterolateral
Papillary
Muscle Time to
Peak Strain (ms)
4511 4412 447 0.82 0.74 0.97
Posteromedial
Papillary Muscle
Strain (%)
-175,9 -20.76.7 -22.56.4 0.10 0.006* 0.85
Posteromedial
Papillary Muscle
Time to Peak
Strain (ms)
4511 4511 486 0.78 0.50 0.80
Interpapillary
Muscle
Asynchrony (ms)
98 109 55 0.65 0.17 0.22
Clinical and echocardiographic characteristics of patients (* p <0.05)
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Objectıve: Diabetic cardiomyopathy is a major complication of diabetes which has
high morbidity and mortality. Diabetic cardiomyopathy is deﬁned as the heart failure
resulting from left ventricular systolic and diastolic dysfunction which is independent
from factors such as coronary artery disease and hypertension. Prediabetes is known as
a strong risk factor for the development of diabetes which needs a long time before
formation of diabetes. Early evaluation of cardiac function is important for the
prevention of target organ damage in prediabetic individuals. The aim of this study is
to evaluate subclinical myocardial dysfunction with a new echocardiographic
modalities method, namely speckle tracking echocardiographic method (AFI), in
prediabetic patients who has preserved left ventricular systolic function which is
evaluated by using conventional echocardiographic method.
Methods: 78 subjects (41 with prediabetes and 37 as control) were included in this
study. All subjects’ conventional, tissue Doppler and longitudinal strain based on
speckle tracking imaging (AFI) data were evaluated by echocardiographic methods.
Results: There were no signiﬁcant differences between the two groups from the aspects
of age, gender, smoking, BMI and blood pressure. The mean longitudinal systolic strain
values (19,22%  2,68% vs 20,37%  2,02, P¼,034) and the ratio of Em/Ea (1,03 
0,22 vs 1,29 0,44, P¼,002) were found signiﬁcantly lower in prediabetic patients than
those in controls, whereas the ratio of E/E’(9,53  2,3 vs 7,61  2,59, P¼,001) was
signiﬁcantly higher. The mean cholesterol (220,22  47,23 vs 191,41  38,83,
P¼,005), LDL (147,06  40,43 vs 119,93  32,76, P¼,002) and trigliserid (155,20 
107,06 vs 88,11  59,53, P¼,001) levels and the measures of mean height (169,00 
8,66 vs 165,11 7,38, P¼,037), weight (78,07 13,31 vs 71,92 13,77, P¼,048) and
waist circumference (90,50 9,70 vs 84,70 10,08, P¼,012) were statistically higher
in prediabetic patients compared with the ones in control group.
Conclusıon: The results of this study revealed that the subclinical LV systolic
dysfunction may develop also in the period of prediabetes before the development of
diabetes. Detection of subclinical LV systolic dysfunction in prediabetic individuals will
contribute to determine high-risk groups for the development of diabetes and its
complications, and also to specify health policies regarding to take preventive eactions.
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Background: The aim of the present study was to analyze anterolateral papillary
muscle longitudinal strain (ALPM-St), posteromedial papillary muscle longitudinal
strain (PMPM-St), anterolateral papillary muscle time to peak longitudinal strain
(ALPM-time), posteromedial papillary muscle time to peak longitudinal strain
(PMPM-time) and asynchrony between papillary muscles in patients with hypertro-
phic cardiomyopathy (HCM), hypertensive left ventricular hypertrophy (H-LVH) and
normal subjects using echocardiography with 2-dimensional speckle tracking imaging
(2D-STI).
Methods: Conventional echocardiography, tissue Doppler imaging, and 2D-STI were
performed in 36 patients with HCM, 10 patients with H-LVH (New York Heart
Association functional class II and preserved ejection fraction) and 10 normal
subjects. All echocardiographic examinations were performed by iE33 and Q-lab
version 8.1 (CMQ, Philips inc). The signiﬁcance of differences between groups was
evaluated by non-parametric analysis (Mann–Whitney test).
Results: We summarized the results in Table 1. In patients with HCM, ALPM St was
lower than in patients with H-LVH and normal subjects (p¼0.009 and p¼0.008,
respectively). No difference was found between H-LVH and normal subjects
(p¼0.9). In assesment of PMPM St there was no difference between H-LVH and
HCM (p¼0.096) but in patients with HCM, PMPM St was lower than normal
subjects (p¼0.006). When we compared the papillary muscles time to peak
longitudinal strain and papillary muscles asynchrony there was no difference
between all groups. Global longitudinal strain was lower in patients with HCM
when compared with H-LVH group and normal subjects (p <0.0001 and p
<0.0001, respectively) but there was no difference between H-LVH and normal
subjects group. HCM patients were analyzed in two subgroups: ALPM St in
patients with obstruction was lower than in patients with non-obstructive
(p¼0.025). And there was asynchrony between papillary muscle in these subgroups
(obstrutive vs. nonobstructive. p¼0.022).
Conclusıon: ALPM St is decreased in patients with HCM and H-LVH. Impairment in
ALPM St in patients with HCM is greater than in patients with H-LVH. In obstructive
HCM patients ALPM St is lower than non-obstructive group. There is no difference
between all groups in papillary muscle asynchrony but in HCM subgroups there is
a signiﬁcant difference. Papillary muscle deformation parameters are different in
patients with HCM, H-LVH and in normal subjects.JACC Vol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTERS C155
